Officials raise awareness on new drug, more potent than fentanyl
Health officials and media outlets are issuing urgent warnings regarding cychlorphine, a synthetic opioid reported to be ten times more potent than fentanyl.
16 trends tracked about this subject — the full history, oldest to newest below.
Health officials and media outlets are issuing urgent warnings regarding cychlorphine, a synthetic opioid reported to be ten times more potent than fentanyl.
1 news sources are covering this Entertainment story right now — PULSE is tracking how fast it spreads.
Coverage reveals Hayden Panettiere's cause of death is linked to fentanyl-laced oxycodone as investigations continue.
6 news sources are covering this Entertainment story right now — PULSE is tracking how fast it spreads.
3 news sources are covering this Entertainment story right now — PULSE is tracking how fast it spreads.
Investigation into the death of actress Hayden Panettiere intensifies as boyfriend Brian Hickerson meets with the DEA amidst family accusations.
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
2 news sources are covering this Entertainment story right now — PULSE is tracking how fast it spreads.
Neutrogena addresses backlash following Hayden Panettiere's death as the DEA joins the ongoing investigation.
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
DEA moves to ban 7‑OH as Trump administration backs kratom allies, sparking state health concerns
6 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
The DEA has formalized the process for an upcoming marijuana rescheduling hearing, sparking debate over participant selection and legal challenges.
The DEA has excluded pro-rescheduling participants from an upcoming hearing, sparking legal challenges from industry stakeholders.
DEA launches on‑site checks of cannabis firms that sought federal protection after Trump’s rescheduling order